Ishara Investments LP

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 2111609 LOS ANGELES, CA

Back to PRAX Full portfolio

Position in PRAX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,549,514

+$284,130 QoQ

Shares Held

22,550

0.0% QoQ

Ownership

0.081%

of shares outstanding

% of Portfolio

5.46%

of 13F equity value

Holder Rank

#102

of 308 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRAX Over Time

Shares Held

Position Value (USD)

Derivatives in PRAX

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

$6,604,895

PutShares

20,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ishara Investments LP holds $128,591,353 across 40 Biotechnology names. PRAX ranks #3 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACAD	Acadia Pharmaceuticals Inc	410,000	$10,373,000
2	BMRN	Biomarin Pharmaceutical Inc	143,500	$8,211,070
3	PRAX	Praxis Precision Medicines, Inc. This page	22,550	$7,549,514
4	RARE	Ultragenyx Pharmaceutical Inc.	205,000	$6,844,950
5	AGIO	Agios Pharmaceuticals, Inc.	164,000	$6,086,040
6	INSM	INSMED Inc	51,250	$5,464,275
7	SION	Sionna Therapeutics, Inc.	123,000	$5,410,770
8	CRNX	Crinetics Pharmaceuticals, Inc.	143,500	$5,369,770

All Filings in PRAX

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,549,514	22,550	0.0%	Shares	Sole	2026-08-14
2026-03-31	$6,604,895	20,500	—	Put	Sole	2026-05-15
2026-03-31	$7,265,384	22,550	-43.6%	Shares	Sole	2026-05-15
2025-12-31	$11,789,600	40,000	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.